Iridex outlines 2025 growth strategy with $10M strategic investment and cost reduction focus

Earnings Call Insights: IRIDEX Corporation (IRIX) Q4 2024 Management View CEO Patrick Mercer emphasized three key themes for 2025: the execution of a cost-reduction program completed in Q4 2024, stabilization of the business particularly in the glaucoma segment, and the strategic investment by.